[Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
The evaluation of disease activity in systemic lupus erythematosus (SLE) is important for selection of the appropriate therapeutic regimen. In addition to the clinical picture, various laboratory parameters are taken into account. However, no validated criteria for the evaluation of the disease activity in SLE have yet been established. Recently, serum levels of soluble interleukin-2 receptor (sIL-2R) have been proposed as a potential parameter for disease activity in SLE. However, the studies reported on this subject so far have focused mainly on certain subsets of the disease, and the evaluation of the disease activity was based on a very limited number of parameters. In the present study, we determined serum levels of sIL-2R in 23 patients with SLE and 30 patients with discoid LE (DLE). Evaluation of disease activity in SLE was based on a comprehensive scale which considered numerous clinical signs and laboratory parameters. In SLE, serum levels of sIL-2R showed a better correlation with disease activity than all the other parameters investigated, including proteinuria, erythrocyte sedimentation rate, serum globulin concentration, titre of antibodies against double-stranded DNA, serum albumin concentration, serum complement levels and white blood cell count. For the first time, we report on elevated serum levels of sIL-2R in DLE, which also correlated with disease activity.
Blum
C
C
Universitäts-Hautklinik Würzburg.
Zillikens
D
D
Tony
H P
HP
Hartmann
A A
AA
Burg
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000974:Antibodies, Antinuclear / Q000032:analysis; D004247:DNA / Q000276:immunology; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis* / Q000276:immunology; D008179:Lupus Erythematosus, Discoid / Q000175:diagnosis* / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000032:analysis*
D000974:Antibodies, Antinuclear; D015375:Receptors, Interleukin-2; D004247:DNA
Der lösliche Interleukin-2-Rezeptor als Aktivitätsparameter im Serum von systemischem und diskoidem Lupus erythematodes.